Free Pediatrics CME 2017‑2018 | CMEList.com

 


Treatment strategies in Hunter Syndrome Free Genetics CME
Posted by...Bernard Sklar, MD.
Free Pulmonology and Genetics CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free.
Instruction Type....Slide-Video Lectures.
Target Audiences....Pediatricians, neurologists, endocrinologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Hunter syndrome.
Educational material last updated...June 29, 2017.
Expiration of CME credit...June 29, 2019.
Financial Support...Shire.
Hunter syndrome is an X-linked recessive genetic disease characterized by a deficiency of lysosomal enzymes responsible for the hydrolysis of glycosaminoglycans (GAGs), with males more likely to develop disease and females more likely to be carriers.
After reviewing Treatment strategies in Hunter Syndrome, you will be able to:
• Describe the importance of earlier treatment and diagnosis of Hunter syndrome in patients
• Determine the likelihood of Hunter syndrome using with established diagnosis methods, given a patient case
• Describe options available to treat Hunter syndrome and design a medical plan to treat a patient with Hunter syndrome
• Describe present barriers to care in the treatment of patients with Hunter syndrome

Lennox-Gastaut Syndrome: Improving Patient Outcomes Through Better Diagnosis and Management Free Neurology CME 
Live online October 7, 2016, and available on demand through October 13, 2017.
Posted by...Bernard Sklar, MD.
Free Neurology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine and Montefiore Medical Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based epileptologists, community neurologists (pediatric and adult), primary care physicians, pediatricians, medical directors from long-term care facilities, and other clinicians involved in the care of patients with Lennox-Gastaut Syndrome.
Educational material updated... October 7, 2016.
Expiration of CME credit... October 13, 2017.
Financial Support...Lundbeck.
Topics covered in Lennox-Gastaut Syndrome include: 
• Barriers to effective diagnosis and management of LGS (Lennox-Gastaut Syndrome) in pediatric and adult settings
• What is the "triad" and evolving seizure patterns of LGS as patients age
• Diagnostic approaches to differentiate LGS from other forms of epileptic encephalopathies
• Management strategies as patients age, seizure characteristics change, and behavioral or other issues arise
• Multidisciplinary approach to lifelong management of LGS and key elements for a smooth transition from pediatric to adult services
At the conclusion of Lennox-Gastaut Syndrome, you will be better able to:
• Identify characteristics associated with LGS from other forms of epilepsy, and evolving seizure profiles over the course of a patient's life
• Devise effective and tolerable pharmacotherapeutic treatment options for LGS as appropriate to pediatric and adult patients
• Evaluate the relative efficacy and safety of alternative therapies and nonpharmacologic strategies for the management of LGS
• Describe the key elements of a care plan that will ensure smooth transition from pediatric care to adult care in patients with LGS

Pediatric Patients with High-Risk Neuroblastoma: Perspectives on Diagnosis and Management Free Cancer CME
Live online June 9, 2016, and available on demand through September 20, 2017.
Posted by...Bernard Sklar, MD.
Free Cancer CME Credit hours...1.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, surgeons, nurses, pharmacists, physician assistants, and health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma.
Educational material updated...June 9, 2016.
Expiration of CME credit...September 20, 2017.
Financial Support...United Therapeutics.
Topics covered by Pediatric Patients with High-Risk Neuroblastoma include:
• Treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments 
• Managing immediate and late effects of therapy for pediatric neuroblastoma 
• Patient-related needs associated with agents used for high-risk pediatric neuroblastoma 
• Current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma
• Collaborative comprehensive care for patients with high-risk pediatric neuroblastoma
• Current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma 
At the conclusion of Pediatric Patients with High-Risk Neuroblastoma, you will be able to:
• Review treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments
• Manage immediate and late effects of therapy for pediatric neuroblastoma
• Describe patient-related needs associated with agents used for high-risk pediatric neuroblastoma
• Evaluate current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma
• Provide collaborative comprehensive care for patients with high-risk pediatric neuroblastoma